Amerikanische Gesellschaft für Hirudotherapie

The Anterolateral Thigh Flap for Achilles Tendon Reconstruction: Functional Outcomes

Research article published in Plastic and reconstructive surgery (2019)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportSicherheit & InfektionskontrolleEhrl D et al. · Plastic and reconstructive surgery, 2019

Abstract

BACKGROUND: Following Achilles tendon rupture and repair, reruptures or infections are not infrequent. Consequently, several surgical techniques have been described to decrease complication rates. This study aimed to evaluate the outcomes of the free composite fasciocutaneous anterolateral thigh flap including fascia lata for reconstruction of combined complex soft-tissue and Achilles tendon defects. METHODS: Within an 8-year period, 34 patients having undergone microvascular Achilles tendon reconstruction fulfilled inclusion criteria for this study: 25 of these patients (73.5 percent) returned for follow-up examination, seven of whom (28.0 percent) underwent additional bilateral contact pressure and power measurements. The data were screened for patients' demographics, intraoperative and perioperative details, flap survival, surgical complications, and overall long-term outcomes. RESULTS: Mean follow-up time was 40.8 months. The Thompson test was negative in all patients. The pain score assessed by the Numerical Rating Scale at the reconstructed site was low overall, but showed significant differences between rest and activity (p < 0.05). The assessment of the Vancouver Scar Scale showed very good results with both techniques. The measurements of the peak pressures, power while walking, and foot contact area did not show differences between the operated and nonoperated sides (p > 0.05), whereas range of motion revealed significant differences (p < 0.05). CONCLUSIONS: In patients who suffer complex Achilles tendon injury requiring free flap coverage, the composite anterolateral thigh flap including fascia lata provides a reliable and safe approach with very good functional and aesthetic outcomes. It should be considered one of the first reconstructive options. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEvaluation StudyJournal Article
Indexed MeSH termsAchilles TendonAdultAgedAged, 80 and overFemaleFree Tissue FlapsGraft SurvivalHumansMaleMiddle AgedPostoperative ComplicationsRupture

Zusammenfassung

Following Achilles tendon rupture and repair, reruptures or infections are not infrequent.

Warum dies für die Hirudotherapie relevant ist

This study evaluated functional outcomes in 25 of 34 eligible patients who underwent Achilles tendon reconstruction using a free composite fasciocutaneous anterolateral thigh flap including fascia lata, with a mean follow-up of 40.8 months. Results demonstrated good functional and aesthetic outcomes, reliable flap survival, and low pain scores. The abstract makes no mention of leeches, hirudin, hirudotherapy, or any leech-derived products. While leech therapy is sometimes used in flap salvage, this study does not address that application or include any leech-related intervention. There is no defensible leech-relevance link for this article within ASH's domain.

Zitation

The Anterolateral Thigh Flap for Achilles Tendon Reconstruction: Functional Outcomes

Ehrl D et al. · Plastic and reconstructive surgery, 2019

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.